SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium, 6 December 2024 – (Euronext Brussels: SEQUA) (the "Company" or "Sequana ...
When you hear about hepatitis A, you may think of tainted food and water, but this liver infection can also be spread from ...
Comprehensive Insights Provided into the Epidemiology Segments and Forecasts, the Future Growth Potential of Diagnosis Rate, Disease Progression, and Diagnostic GuidelinesDublin, Dec. 05, 2024 (GLOBE ...
Learn about eletriptan (Relpax), an effective migraine treatment that outperforms other triptans. Discover its benefits and ...
The symptoms of UC are unpredictable. On a given day it can cause an urge to use the bathroom repeatedly, or blood in your ...
AstraZeneca's IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...
Dr. Christopher Kahler always wanted a career exploring "how people make meaning out of their lives." He planned to teach ...
Ovarian cancer took my beautiful mum, and it makes me angry – angry that in this century, treatment options have barely ...
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast ...
Cancer, unfortunately, has become the leading disease related cause of death for dogs and cats. It is estimated that 1 in 4 ...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the presentation of the Phase 3 ...
Based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo AstraZeneca's IMFINZI (durvalumab) has been approved in the US for the treatment of adult ...